ECHO THERAPEUTICS, INC. FILES (8-K) Disclosing Change in Directors or Principal Officers
(Edgar Glimpses Via Acquire Media NewsEdge) Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Appointment of Certain Officers
On June 30, 2014, the Board of Directors (the "Board") of Echo Therapeutics,
Inc. ("Echo" or the "Company") appointed Kimberly A. Burke to serve as Interim
Chief Executive Officer of Echo, effective July 1, 2014 and continuing for the
sixty-day period expiring on August 30, 2014 or, if earlier, such date as a
candidate is identified and appointed by the Board to serve as Echo's Chief
Executive Officer. Ms. Burke will also serve as Echo's principal executive
officer. The Board is currently working with a retained executive search firm to
identify qualified candidates to serve as Echo's Chief Executive Officer.
There are no arrangements or understandings between Ms. Burke and any other
persons pursuant to which she was appointed as Interim Chief Executive Officer
of Echo. There are also no family relationships between Ms. Burke and any
director or executive officer of Echo, and Ms. Burke has no direct or indirect
material interest in any transaction required to be disclosed pursuant to
Item 404(a) of Regulation S-K. In addition, to date, Echo has not entered into
any new compensatory or severance arrangements with Ms. Burke in connection with
Ms. Burke's appointment as Interim Chief Executive Officer of Echo. In addition
to serving as Interim Chief Executive Officer, Ms. Burke will also continue to
serve as the General Counsel and Chief Compliance Officer of Echo.
Ms. Burke, 40 years old, was appointed as Echo's General Counsel and Senior Vice
President in January 2011, as Chief Compliance Officer in April 2012, and she
has served as Echo's Secretary since 2010. Ms. Burke joined the Company as Vice
President, Corporate Counsel in 2008 after serving as General Counsel of
privately-held Echo Therapeutics, Inc. from 2004 until its merger with Sontra
Medical Corporation to form the Company in 2007. Prior to Echo, Ms. Burke was
Director of Legal Affairs at Cato Research Ltd., a global contract research and
development organization, and an Associate with Cato BioVentures. Ms. Burke has
also held prior legal positions at Devine, Millimet and Branch, a New England
law firm, Investors Title Company, a holding company engaged in title insurance
and investment management services, and Hemodynamic Therapeutics, a
pharmaceutical company. Ms. Burke received her B.A. from Mount Holyoke College
and her J.D. from the College of William and Mary, Marshall-Wythe School of Law.
Departure of Certain Officers
Effective at midnight on June 30, 2014, Robert F. Doman's consulting contract
with Echo expired in accordance with its terms and, accordingly, he no longer
serves as the Interim Chief Executive Officer of Echo.
On July 1, 2014, Christopher P. Schnittker resigned as Senior Vice President and
Chief Financial Officer of Echo to accept another opportunity. Mr. Schnittker's
resignation is effective as of July 15, 2014. Echo has initiated a search for a
new Chief Financial Officer.
[ Back To TMCnet.com's Homepage ]